Sign in to view content

Interaction of Genotypes and AREDS Formulation Use in the Development of Neovascular AMD

Pradeepa Yoganathan, MSc, MD, FRCS(C)

Video
Published 2019

Pradeepa Yoganathan, MD, FRCS(C)

AMD Neovascular Part II Symposium

Related

Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes with Nonexudative AMD Trial (PREVENT): A Prospective Controlled
Maziar Lalezary, MD
Updates from the Field
2018
PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results
John A. Wells, MD, FACS
Updates from the Field
2025
Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2018

Category: AMD-Neovascular

See more